Results 151 to 160 of about 70,385 (287)
Electrodiagnosis of demyelinating neuropathies.
The inflammatory demyelinating neuropathies constitute a significant proportion of the acquired polyneuropathies. Major progress in finding the causes and in the treatment of these neuropathies has been made over the last decade.
Jacquerye, P. +2 more
core
Inborn errors of immunity in children with neuroinflammation
Abstract Inborn errors of immunity (IEIs), an expanding group of monogenic disorders with diverse clinical manifestations, are increasingly recognized to include neuroinflammatory disease. Examples of diseases included under this umbrella are Aicardi–Goutières syndrome, deficiency of adenosine deaminase 2, familial haemophagocytic lymphohistiocytosis ...
Eppie M Yiu +5 more
wiley +1 more source
FGF/FGFR system in the central nervous system demyelinating disease: Recent progress and implications for multiple sclerosis. [PDF]
Zhang Q, Chen Z, Zhang K, Zhu J, Jin T.
europepmc +1 more source
Abstract Idiopathic multicentric Castleman disease (iMCD) is a rare condition. The pathogenesis is incompletely understood; however, interleukin‐6 (IL‐6) is a major mediator. The clinical presentation is heterogeneous, from mild constitutional symptoms to severe multi‐organ failure.
Dipti Talaulikar +16 more
wiley +1 more source
Spinal Dural Arteriovenous Fistula: A Mimic of Demyelinating Disease and Radiculopathy. [PDF]
Alfaro-Olivera M +7 more
europepmc +1 more source
Abstract Background Chronic inflammatory demyelinating polyneuropathy (CIDP) is commonly treated with long‐term intravenous immunoglobulin (IVIg). Individual dosing requirements and duration of IVIg differ among patients, leading to significant heterogeneity in IVIg utilisation.
Kristina T. Pidd, Anthony Khoo
wiley +1 more source
Semliki Forest virus induced, immune mediated demyelination: the effect of irradiation
Intraperitoneal infection with the avirulent A7(74) strain of the alphavirus Semliki Forest virus (SFV) induces an immune mediated demyelinating encephalomyelitis.
Fazakerley, J K, Webb, H E
core
Narcolepsy and rapid eye movement sleep
Summary Since the first description of narcolepsy at the end of the 19th Century, great progress has been made. The disease is nowadays distinguished as narcolepsy type 1 and type 2. In the 1960s, the discovery of rapid eye movement sleep at sleep onset led to improved understanding of core sleep‐related disease symptoms of the disease (excessive ...
Francesco Biscarini +4 more
wiley +1 more source
CNS demyelinating disease following inactivated or viral vector SARS-CoV-2 vaccines: A case series. [PDF]
Ebrahimi N +3 more
europepmc +1 more source
Aim Major depressive disorder (MDD) is a leading cause of disability and carries a high risk of suicide. MicroRNAs (miRNAs) are epigenetic regulators implicated in MDD and can be regulated by DNA methylation, potentially reshaping downstream gene networks.
Aleena Francis, Yogesh Dwivedi
wiley +1 more source

